Can-Fite BioPharma CANF
NYSE CANF
$1.89 0.00 (-0.02%)
As of: Oct 21, 2026 · 3:21 PM EDT

Can-Fite BioPharma (CANF) Current Leases (2019 - 2020)

Updated

Can-Fite BioPharma (CANF) reported Current Leases of $43,000 for Q4 2020, up 19.4% from $36,000 a year earlier.

Analysis

Can-Fite BioPharma (CANF) Current Leases (2019 - 2020) Analysis & Trends

Dating back to Q4 2016, Can-Fite BioPharma's Current Leases record includes 4 quarters.

  • Current Leases has a four-year compound annual growth rate of -74.1% (FY2016 to FY2020).
  • By year, Current Leases came in at $36,000 in FY2019, $6.25 million in FY2017 (-35.1%) and $9.63 million in FY2016.
  • The Q4 2020 figure ranks as the highest quarterly Current Leases since Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Can-Fite BioPharma 1.56 Mn -18.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 43,000.00
Dec 31, 2019 36,000.00
API Access

Can-Fite BioPharma Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CANF&period=max&api_key=YOUR_API_KEY